Medicare is in for a busy 2025. With a growing aging population, increasingly attractive economics and an incoming Administration who is bullish on the space, Medicare Advantage may be on an upward trajectory. The MA market can be a testing ground for innovative healthcare delivery and reimbursement models, but prior authorization struggles continue to be a hurdle for health systems and 90% of MA beneficiaries are at risk of reduced benefits in 2025. Reimbursement rates from commercial insurers continue to significantly outpace government payments, making MA an increasingly attractive option for both providers and patients. Where will the scales tip between traditional Medicare and MA over the next few years? The landscape appears favorable for MA expansion, positioning it as a key strategic platform for reimagining Medicare's future, with a focus on value-based care, preventive services, and more adaptable healthcare approaches, but only time and a new CMS will tell.